| Literature DB >> 30486491 |
Andres Bernal-Ballen1, Jorge Lopez-Garcia2, Martha-Andrea Merchan-Merchan3, Marian Lehocky4.
Abstract
Bio-artificial polymeric systems are a new class of polymeric constituents based on blends of synthetic and natural polymers, designed with the purpose of producing new materials that exhibit enhanced properties with respect to the individual components. In this frame, a combination of polyvinyl alcohol (PVA) and chitosan, blended with a widely used antibiotic, sodium ampicillin, has been developed showing a moderate behavior in terms of antibacterial properties. Thus, aqueous solutions of PVA at 1 wt.% were mixed with acid solutions of chitosan at 1 wt.%, followed by adding ampicillin ranging from 0.3 to 1.0 wt.% related to the total amount of the polymers. The prepared bio-artificial polymeric system was characterized by FTIR, SEM, DSC, contact angle measurements, antibacterial activity against Staphylococcus aureus and Escherichia coli and antibiotic release studies. The statistical significance of the antibacterial activity was determined using a multifactorial analysis of variance with ρ < 0.05 (ANOVA). The characterization techniques did not show alterations in the ampicillin structure and the interactions with polymers were limited to intermolecular forces. Therefore, the antibiotic was efficiently released from the matrix and its antibacterial activity was preserved. The system disclosed moderate antibacterial activity against bacterial strains without adding a high antibiotic concentration. The findings of this study suggest that the system may be effective against healthcare-associated infections, a promising view in the design of novel antimicrobial biomaterials potentially suitable for tissue engineering applications.Entities:
Keywords: ampicillin; bio-artificial polymeric system; chitosan; health-care associated infections; polyvinyl alcohol
Mesh:
Substances:
Year: 2018 PMID: 30486491 PMCID: PMC6321558 DOI: 10.3390/molecules23123109
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1FTIR spectra for BAPS. (A). Polymers with and without lactic acid and glutaraldehyde (ADD): (a) PVA; (b) PVA/ADD; (c) CHI; (d) CHI/ADD. (B) PVA blends: (a) PVA/AMP 0.3%; (b) PVA/AMP 1%; (c) PVA/ADD/AMP 0.3%; (d) PVA/ADD/AMP 1.0%; (C) CHI blends: (a) CHI/AMP 0.3%; (b) CHI/AMP 1.0%; (c) CHI/ADD/AMP 0.3%; (d) CHI/ADD/AMP 1.0%; (D) PVA/CHI blends: (a) PVA/CHI/ADD/AMP 0.3%; (b) PVA/CHI/ADD/AMP 1.0%.
Figure 2Cross section and surface SEM images of the Bioartificial polymeric systems (BAPS): (A) PVA/ADD/AMP. (B) CHI/ADD/AMP. (C) PVA/CHI/ADD/AMP.
Figure 3Thermogram for BAPS. (A). Polymers with and without ADD: (a) CHI; (b) CHI/ADD; (c) PVA; (d) PVA/ADD; (B) PVA blends: (a) PVA/AMP 0.3%; (b) PVA/AMP 1%; (c) PVA/ADD/AMP 0.3%; (d) PVA/ADD/AMP 1.0%; (C) CHI blends: (a) CHI/AMP 0.3%; (b) CHI/AMP 1.0%; (c) CHI/ADD/AMP 0.3%; (d) CHI/ADD/AMP 1.0%; (D) PVA/CHI blends: (a) PVA/CHI/ADD/AMP 0.3%; (b) PVA/CHI/ADD/AMP 1.0%.
Contact angle values for the prepared materials.
| Description | Contact Angle (°) | ||
|---|---|---|---|
|
|
|
| |
| PVA | <10 * | <10 | 34.93 ± 5.33 |
| CHI | <10 * | <10 | 45.33 ± 1.71 |
| PVA/AMP 0.3% | <10 * | *** | 35.24 ± 4.97 |
| PVA/AMP 1.0% | <10 * | *** | 41.46 ± 3.82 |
| CHI/AMP 0.3% | <10 * | 55.76 ± 4.75 | 45.55 ± 3.34 |
| CHI/AMP 1.0% | <10 * | 47.73 ± 6.54 | 45.56 ± 3.02 |
| PVA/ADD/AMP 0.3% | 61.14 ± 4.13 ** | *** | 22.94 ± 2.00 |
| PVA/ADD/AMP 1.0% | 43.12 ± 1.62 ** | *** | 34.35 ± 2.59 |
| CHI/ADD/AMP 0.3% | <10 * | *** | 45.51 ± 3.45 |
| CHI/ADD/AMP 1.0% | <10 * | *** | 44.24 ± 5.69 |
| PVA/CHI/ADD/AMP 0.3% | 62.43 ± 3.82 ** | 44.36 ± 2.65 | 45.06 ± 2.61 |
| PVA/CHI/ADD/AMP 1.0% | 53.91 ± 2.67 ** | 43.22 ± 1.93 | 51.58 ± 3.88 |
* In these cases the samples are hydrophilic and the surface got wet very quickly. ** Although the samples have a water contact angle, the specimens got swollen in approximately 5 s. *** It reacted with the solvent.
Figure 4Images for contact angle measurements. (A) PVA/CHI/ADD/AMP 0.3% (ethylene glycol); (B) PVA/CHI/ADD/AMP 0.3% (diiodomethane); (C) PVA/CHI/ADD/AMP 1.0% (ethylene glycol) (D). PVA/CHI/ADD/AMP 1.0% (diiodomethane).
Agar diffusion test of the studied sample against Staphylococcus aureus and Escherichia coli.
| Sample | Inhibition Zone (mm) | Inhibition Zone (mm) |
|---|---|---|
| PVA | - | - |
| CHI | - | - |
| PVA/AMP 0.3% | 2.34 ± 0.69 | - |
| PVA/AMP 1.0% | 3.54 ± 0.60 | 1.26 ± 0.05 |
| * CHI/AMP 0.3% | 3.26 ± 0.87 | - |
| * CHI/AMP 1.0% | 4.36 ± 0.35 | - |
| PVA/ADD/AMP 0.3% | - | 1.27 ± 0.17 |
| PVA/ADD/AMP 1.0% | 1.30 ± 0.17 | 1.13 ± 0.05 |
| * CHI/ADD/AMP 0.3% | 3.61 ± 0.31 | 1.16 ± 0.21 |
| * CHI/ADD/AMP 1.0% | 4.18 ± 0.21 | 1.10 ± 0.16 |
| * PVA/CHI/ADD/AMP 0.3% | 1.18 ± 0.04 | - |
| * PVA/CHI/ADD/AMP 1.0% | 1.20 ± 0.10 | - |
* ANOVA test showed that CHI was the unique component which its significance was higher than ρ < 0.05.
Figure 5Inhibition zone for BAPS. (A,B) PVA/AMP 1.0% against Staphylococcus aureus and Escherichia coli. (C,D) PVA/ADD/AMP 1.0% against Staphylococcus aureus and Escherichia coli. (E,F) CHI/ADD/AMP 1.0% against Staphylococcus aureus and Escherichia coli. (G) PVA/CHI/ADD/AMP 0.3% against Staphylococcus aureus (H) PVA/CHI/ADD/AMP 1.0% against Staphylococcus aureus.
Release studies of AMP from the prepared samples.
| % AMP | CMAX (μg/g) | −k × 10−3 (1/h) | R2 |
|---|---|---|---|
| PVA/AMP 0.3% | 26.69 ± 0.94 | 43.1 | 0.90 |
| PVA/AMP 1.0% | 70.54 ± 0.71 | 53.8 | 0.90 |
| CHI/AMP 0.3% | 27.11 ± 0.85 | 45.5 | 0.90 |
| CHI/AMP 1.0 % | 75.90 ± 2.09 | 70.5 | 0.90 |
| PVA/ADD/AMP 0.3% | 27.13 ± 0.40 | 0.40 | 0.90 |
| PVA/ADD/AMP 1.0% | 75.60 ± 1.63 * | 0.45 | 0.90 |
| CHI/ADD/AMP 0.3% | 27.12 ± 0.44 | 57.9 | 0.90 |
| CHI/ADD/AMP 1.0% | 73.00 ± 2.16 | 68.7 | 0.95 |
| PVA/CHI/ADD/AMP 0.3% | 78.28 ± 0.23 * | 0.33 | 0.95 |
| PVA/CHI/ADD/AMP 1.0% | 78.74 ± 2.58 * | 0.41 | 0.95 |
* These values were obtained after 24 h. The others after 6 h.
Figure 6Release profile of AMP from BAPS measured by UV-VIS spectrophotometer.